生物
细胞生长
癌症研究
分子生物学
化学
生物化学
作者
Hao Jiang,Ning Ma,Yu‐Rong Shang,Wentao Zhou,Tianwei Chen,Dongxian Guan,Jingjing Li,Jingjing Wang,Er‐Bin Zhang,Yuanyuan Feng,Fenfen Yin,Yanmei Yuan,Yuanyuan Fang,Lin Qiu,Dong Xie,Dongzhi Wei
标识
DOI:10.1016/j.bbrc.2016.11.156
摘要
Metabolic dysregulation is one of the most common and recognizable features of cancer. Triosephosphate isomerase 1 (TPI1), which catalyzes the interconversion of dihydroxyacetone phosphate (DHAP) and d-glyceraldehyde-3-phosphate (G3P) during glycosis and gluconeogenesis, is a crucial enzyme in the carbohydrate metabolism. However, the biological function and mechanism of TPI1 in cancer remain largely unknown. In this study, we have found that TPI1 expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis. Forced expression of TPI1 in HCC cells inhibited cell growth, migration, and invasion in vitro. Consistently, knockdown of TPI1 by shRNA promoted cell growth, migration and invasion. Moreover, overexpression of TPI1 led to slowed tumor growth and decreased tumor weight in vivo. Furthermore, cell cycle arrest was induced by TPI1 overexpression. These phenotypes were associated with altered expression of β-catenin, Vimentin, P53, P27 and CyclinD1. Therefore, our data suggested that TPI1 functioned as a tumor suppressor in HCC and might serve as a potential therapeutic target for the treatment of HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI